Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques
- 1 April 2002
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 123 (4) , 686-694
- https://doi.org/10.1067/mtc.2002.120713
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trialThe Annals of Thoracic Surgery, 2000
- Sequence-dependent enhancement of paclitaxel toxicity in non–small cell lung cancer by 17-allylamino 17-demethoxygeldanamycinThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Long-term results of lung metastasectomy: Prognostic analyses based on 5206 casesThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Treatment of the patient with lung metastasesCurrent Problems in Surgery, 1996
- Isolated lung perfusion with platinum in the treatment of pulmonary metastases from soft tissue sarcomasThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Isolated lung perfusion with tumor necrosis factor for pulmonary metastasesThe Annals of Thoracic Surgery, 1996
- Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinomaThe Journal of Thoracic and Cardiovascular Surgery, 1995
- High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol®) in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Arterial Drug Infusion: Pharmacokinetic Problems and PitfallsJNCI Journal of the National Cancer Institute, 1988
- Pharmacologic rationale for regional drug delivery.Journal of Clinical Oncology, 1984